{{Rsnum
|rsid=649891
|Gene=PTPRD
|Chromosome=9
|position=10430602
|Orientation=minus
|GMAF=0.4995
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 61.9 | 35.4 | 2.7
| HCB | 5.3 | 42.9 | 51.9
| JPT | 8.9 | 39.3 | 51.8
| YRI | 1.4 | 38.9 | 59.7
| ASW | 12.3 | 49.1 | 38.6
| CHB | 5.3 | 42.9 | 51.9
| CHD | 5.7 | 35.8 | 58.5
| GIH | 30.7 | 52.5 | 16.8
| LWK | 9.4 | 33.0 | 57.5
| MEX | 24.1 | 48.3 | 27.6
| MKK | 7.8 | 43.1 | 49.0
| TSI | 60.8 | 32.4 | 6.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21647700
|Trait=None
|Title=Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals.
|RiskAllele=C
|Pval=0.000006
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}